CSIMarket
 
Minerva Surgical Inc   (UTRS)
Other Ticker:  
 
 
Price: $0.5500 $0.00 0.000%
Day's High: $0.55 Week Perf: -11.29 %
Day's Low: $ 0.55 30 Day Perf: -17.91 %
Volume (M): 0 52 Wk High: $ 14.00
Volume (M$): $ 0 52 Wk Avg: $3.32
Open: $0.55 52 Wk Low: $0.33



 Market Capitalization (Millions $) 5
 Shares Outstanding (Millions) 9
 Employees -
 Revenues (TTM) (Millions $) 50
 Net Income (TTM) (Millions $) -33
 Cash Flow (TTM) (Millions $) 29
 Capital Exp. (TTM) (Millions $) 0

Minerva Surgical Inc
Minerva Surgical Inc is a medical technology company that specializes in the development and manufacturing of innovative solutions for women's health. The company focuses on providing minimally invasive treatments for conditions such as abnormal uterine bleeding and other gynecological diseases. Minerva Surgical's flagship product is the MiniArc Precise system, which offers a less invasive surgical option for treating uterine fibroids. The company aims to improve the quality of life for women by offering effective and safe solutions that minimize pain and recovery time.


   Company Address: 4255 Burton Dr. Santa Clara 95054 CA
   Company Phone Number: 646-7874   Stock Exchange / Ticker: NASDAQ UTRS
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Minerva Surgical Inc

Minerva Surgical Inc. Celebrates Remarkable Recovery as Losses Swiftly Dissipate in Q3 of 2023 Earnings Season



Minerva Surgical Inc, a leading player in the Medical Equipment & Supplies sector, witnessed a notable decline in its shares over the last five trading days, resulting in an overall year-to-date performance slump of -51.59%. Furthermore, the company's financial results for the third quarter of 2023 reveal a reduction in losses alongside decreasing revenue. This article aims to explore the implications of these developments and their potential impact on Minerva Surgical Inc's future prospects.
1. Share performance decline:
Minerva Surgical Inc experienced a significant drop of -11.62% in its shares over the past five trading days. This downward trend has contributed to a concerning year-to-date performance decrease of -51.59%. These figures indicate that investor confidence in the company has waned, potentially leading to challenges related to funding and overall market perception.

Minerva Surgical Inc

Minerva Surgical Inc Tackles Tough Q2 2023 Despite Minor Decline in Revenue and Rising Inventories

Minerva Surgical Inc, a medical technology company specializing in advanced surgical equipment, is experiencing a challenging second quarter in 2023. As the company's revenues decreased by 4.357% to $12.40 million, it faced diminishing returns and a net shortfall of $-8.681 million. These financial results were in stark contrast to the same quarter from the previous year, where the company had a revenue increase and lower shortfall per share.
One notable aspect of Minerva Surgical Inc's recent performance is the build-up in inventories. The level of inventories and supplies has increased to $17.9 million, which is higher than in both the preceding quarter and the corresponding quarter a year ago. This indicates that Minerva Surgical Inc has been producing more equipment to meet rising demand, even though its overall financial numbers have declined.

Minerva Surgical Inc

Minerva Surgical Inc's Staggering Revenue Growth Fails to Attain Profitability in Q1, 2023

Minerva Surgical Inc is a medical technology company based in Redwood City, California, which focuses on developing and commercializing innovative devices to treat women's health conditions. The company was founded in 2008, and it has been growing rapidly, thanks to its cutting-edge products that provide women with more effective and less invasive treatments for common gynecological problems.
Despite its impressive revenue growth, in the first quarter of 2023, the company registered a net loss of $-11.343 million, which is a significant increase from the $-10.925 million loss recorded in the same period a year ago. Additionally, the company's earnings per share fell from $-0.11 to $-0.12 per share. Despite this slowdown, the company is still expected to report its next financial results on May 10, 2023, with analysts eagerly anticipating the release of its latest financial metrics.






 

Minerva Surgical Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com